La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Ardelyx Gestione
Gestione criteri di controllo 3/4
Ardelyx's Il CEO è Mike Raab, nominato in Mar2009, e ha un mandato di 15.42 anni. la retribuzione annua totale è $ 4.12M, composta da 17% di stipendio e 83% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.55% delle azioni della società, per un valore di $ 7.51M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 4.2 anni e 8.8 anni.
Informazioni chiave
Mike Raab
Amministratore delegato
US$4.1m
Compenso totale
| Percentuale dello stipendio del CEO | 17.0% |
| Mandato del CEO | 15.5yrs |
| Proprietà del CEO | 0.5% |
| Durata media del management | 4.3yrs |
| Durata media del Consiglio di amministrazione | 8.9yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Is Ardelyx (NASDAQ:ARDX) Weighed On By Its Debt Load?
Aug 25
Party Time: Brokers Just Made Major Increases To Their Ardelyx, Inc. (NASDAQ:ARDX) Earnings Forecasts
Aug 07Ardelyx Faces Rising Challenges Despite Revenue Growth
Aug 05Earnings Beat: Ardelyx, Inc. (NASDAQ:ARDX) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
Aug 04Ardelyx: Increased Focus On Ibsrela Due To Xphozah's Uncertain Outlook
Jul 13Why Investors Shouldn't Be Surprised By Ardelyx, Inc.'s (NASDAQ:ARDX) 25% Share Price Plunge
Jul 05Ardelyx: Strong Execution, Fairly Valued
May 10Ardelyx, Inc. (NASDAQ:ARDX) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates
May 04Ardelyx Stock: A Crowded Market Curbs The Enthusiasm (Rating Downgrade)
May 03Ardelyx, Inc.'s (NASDAQ:ARDX) Popularity With Investors Is Under Threat From Overpricing
Apr 17Ardelyx Shrugs Off 'Mixed' Q4 Earnings
Mar 13Earnings Update: Ardelyx, Inc. (NASDAQ:ARDX) Just Reported Its Yearly Results And Analysts Are Updating Their Forecasts
Feb 24Ardelyx Q4 Preview: Recent Bull Run May Pause While Market Digests 2024 Guidance
Feb 20Ardelyx's XPHOZAH Still An Afterthought To The Pros
Jan 31Ardelyx: FDA Approval For Xphozah Grants Further Sales Enhancement
Jan 10Ardelyx, Inc.'s (NASDAQ:ARDX) Business Is Yet to Catch Up With Its Share Price
Jan 04Despite Lacking Profits Ardelyx (NASDAQ:ARDX) Seems To Be On Top Of Its Debt
Dec 14Party Time: Brokers Just Made Major Increases To Their Ardelyx, Inc. (NASDAQ:ARDX) Earnings Forecasts
Aug 03Rock star Growth Puts Ardelyx (NASDAQ:ARDX) In A Position To Use Debt
Jul 31Pinning Down Ardelyx, Inc.'s (NASDAQ:ARDX) P/S Is Difficult Right Now
Apr 17Is Ardelyx (NASDAQ:ARDX) Using Debt Sensibly?
Mar 30Is Ardelyx (NASDAQ:ARDX) Using Debt Sensibly?
Dec 14What To Expect For Ardelyx In The Coming Month
Oct 18Ardelyx: Potential For Growth, But Must Strengthen Its Financial Position
Oct 04Ardelyx secures $20M financial deal with HealthCare Royalty on tenapanor potential sale
Jun 30Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$65m |
| Mar 31 2024 | n/a | n/a | -US$66m |
| Dec 31 2023 | US$4m | US$700k | -US$66m |
| Sep 30 2023 | n/a | n/a | -US$27m |
| Jun 30 2023 | n/a | n/a | -US$56m |
| Mar 31 2023 | n/a | n/a | -US$66m |
| Dec 31 2022 | US$2m | US$650k | -US$67m |
| Sep 30 2022 | n/a | n/a | -US$114m |
| Jun 30 2022 | n/a | n/a | -US$135m |
| Mar 31 2022 | n/a | n/a | -US$153m |
| Dec 31 2021 | US$4m | US$650k | -US$158m |
| Sep 30 2021 | n/a | n/a | -US$151m |
| Jun 30 2021 | n/a | n/a | -US$125m |
| Mar 31 2021 | n/a | n/a | -US$105m |
| Dec 31 2020 | US$4m | US$633k | -US$94m |
| Sep 30 2020 | n/a | n/a | -US$85m |
| Jun 30 2020 | n/a | n/a | -US$91m |
| Mar 31 2020 | n/a | n/a | -US$91m |
| Dec 31 2019 | US$2m | US$595k | -US$95m |
| Sep 30 2019 | n/a | n/a | -US$103m |
| Jun 30 2019 | n/a | n/a | -US$104m |
| Mar 31 2019 | n/a | n/a | -US$100m |
| Dec 31 2018 | US$4m | US$575k | -US$91m |
| Sep 30 2018 | n/a | n/a | -US$53m |
| Jun 30 2018 | n/a | n/a | -US$50m |
| Mar 31 2018 | n/a | n/a | -US$53m |
| Dec 31 2017 | US$5m | US$555k | -US$64m |
Compensazione vs Mercato: La retribuzione totale di Mike ($USD 4.12M ) è circa la media per le aziende di dimensioni simili nel mercato US ($USD 5.62M ).
Compensazione vs guadagni: La retribuzione di Mike è aumentata nonostante l'azienda non sia redditizia.
AMMINISTRATORE DELEGATO
Mike Raab (59 yo)
15.5yrs
Mandato
US$4,118,144
Compensazione
Mr. Michael G. Raab, also known as Mike, has been the Chief Executive Officer and President of Ardelyx, Inc. since March 2009. He is a Director of Tempest Therapeutics Inc. since May 2019 and its Chairman...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| President | 15.5yrs | US$4.12m | 0.53% $ 8.3m | |
| Chief Legal & Administrative Officer and Secretary | 10.3yrs | US$1.63m | 0.082% $ 1.3m | |
| Chief Medical Officer | 3.8yrs | US$1.63m | 0.13% $ 2.1m | |
| Chief Financial & Operations Officer | 4.3yrs | US$1.73m | 0.13% $ 2.0m | |
| Senior VP of Finance & Chief Accounting Officer | 2.5yrs | Nessun dato | 0.039% $ 608.9k | |
| Vice President of Corporate Communications & Investor Relations | no data | Nessun dato | Nessun dato | |
| Executive Vice President of Corporate Development & Strategy | less than a year | Nessun dato | Nessun dato | |
| Chief Human Resources Officer | 1.7yrs | Nessun dato | Nessun dato | |
| Chief Development Officer | 9.7yrs | US$1.63m | 0.25% $ 3.9m | |
| Chief Regulatory Affairs & Quality Assurance Officer | no data | US$1.70m | 0.14% $ 2.1m | |
| Advisor | 4.3yrs | US$1.04m | 0.19% $ 3.0m | |
| Manager of Corporate Communications & Investor Relations | no data | Nessun dato | Nessun dato |
4.3yrs
Durata media
60yo
Età media
Gestione esperta: Il team dirigenziale di ARDX è considerato esperto (durata media dell'incarico 4.2 anni).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| President | 15.5yrs | US$4.12m | 0.53% $ 8.3m | |
| Independent Chairman of the Board | 15.5yrs | US$249.90k | 0.51% $ 8.0m | |
| Independent Director | 8.9yrs | US$214.90k | 0.098% $ 1.5m | |
| Independent Director | 10.5yrs | US$222.40k | 0.11% $ 1.7m | |
| Independent Director | 8.3yrs | US$202.40k | Nessun dato | |
| Independent Director | 4.5yrs | US$199.90k | 0.047% $ 732.5k | |
| Independent Director | 3.5yrs | US$202.40k | 0.041% $ 637.0k |
8.9yrs
Durata media
59yo
Età media
Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di ARDX sono considerati esperti (durata media dell'incarico 8.8 anni).